Trimethoprim-Sulfamethoxazole DS: Difference between revisions

No edit summary
Line 22: Line 22:
**15-20 mg/kg/dy TMP PO divided q6-8h
**15-20 mg/kg/dy TMP PO divided q6-8h


==Special Populations==
*Pregnancy: D
*Lactation: ?
*Renal (Adult & Pediatric)
**CrCl 15-30: Decrease dose by 50%
**CrCl <15: Avoid use
**Hemodialysis: Give supplement
**Peritoneal Dialysis: No supplement
*Hepatic (Adult & Pediatric)
**Mild-mod impairment: Caution advised
**Significant impairment: Contraindicated
==Contraindications==
==Contraindications==
*Allergy to class/drug
*Allergy to class/drug
Line 77: Line 88:
*Excretion:  
*Excretion:  
*Mechanism of Action: Bactericidal
*Mechanism of Action: Bactericidal
==Special Populations==
*Pregnancy: D
*Lactation: ?
*Renal (Adult & Pediatric)
**CrCl 15-30: Decrease dose by 50%
**CrCl <15: Avoid use
**Hemodialysis: Give supplement
**Peritoneal Dialysis: No supplement
*Hepatic (Adult & Pediatric)
**Mild-mod impairment: Caution advised
**Significant impairment: Contraindicated


==See Also==
==See Also==
Line 94: Line 93:


==Source==
==Source==
*Epocrates


[[Category:Drugs]]
[[Category:Drugs]]

Revision as of 22:24, 27 February 2014

General

  • Type: Sulfonamide
  • Dosage Forms: 160/800
  • Common Trade Names: Bactrim DS
  • Abbreviations: TMP-SMX, TMP-SMZ

Adult Dosing

General

1 tab (160mg TMP) PO Q12h

PCP Prophylaxis

80-160mg TMP PO daily

PCP Treatment

15-20 mg/kg/day TMP PO divided q6-8h x 21 days

Pediatric Dosing

General (>2mo)

  • Mild-mod infection
    • 4-5 mg/kg TMP PO q12hr
  • Severe infection
    • 15-20 mg/kg/dy TMP PO divided q6-8h

Special Populations

  • Pregnancy: D
  • Lactation: ?
  • Renal (Adult & Pediatric)
    • CrCl 15-30: Decrease dose by 50%
    • CrCl <15: Avoid use
    • Hemodialysis: Give supplement
    • Peritoneal Dialysis: No supplement
  • Hepatic (Adult & Pediatric)
    • Mild-mod impairment: Caution advised
    • Significant impairment: Contraindicated

Contraindications

  • Allergy to class/drug
  • <2 months of age (except as PCP prophylaxis)
  • Significant hepatic impairment
  • Megaloblastic anemia or folate deficiency
  • G6PD deficiency

Adverse Reactions

Serious

Common

Pharmacology

  • Half-life: 6-12h (20-50h ESRD)
  • Metabolism:
  • Excretion:
  • Mechanism of Action: Bactericidal

See Also

Source

  • Epocrates